https://www.indianpharmapost.com/dcgi-approves-astrazeneca-s-olaparib-film-coated-tablets-128752022-08-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-medicare-completes-clinical-studies-of-high-concentration-biosimilar-adalimumab-128762022-08-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/godrej-reveals-how-to-win-the-war-against-malaria-through-strategic-collaboration-128772022-08-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/european-medicines-agency-accepts-menarinis-application-for-elacestrant-128782022-08-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/swissmedic-approves-kapruvia-with-additional-regulatory-decisions-expected-in-h2-2022-128792022-08-20T00:00:00+05:30always0.9